Dogwood Therapeutics (DWTX) to Release Earnings on Thursday

Dogwood Therapeutics (NASDAQ:DWTX) is expected to be announcing its earnings results before the market opens on Thursday, March 6th. Analysts expect Dogwood Therapeutics to post earnings of ($1.49) per share for the quarter.

Dogwood Therapeutics Stock Up 2.2 %

Shares of DWTX stock opened at $5.12 on Thursday. The company’s 50 day simple moving average is $5.99. The stock has a market cap of $6.82 million, a PE ratio of -0.78 and a beta of 1.92. Dogwood Therapeutics has a 12 month low of $1.62 and a 12 month high of $29.28.

Dogwood Therapeutics Company Profile

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.